HI
TXMD icon

Harbour Investments’s TherapeuticsMD TXMD Stock Holding History

Harbour Investments’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16 Hold
8
– – ﹤0.01% 4631
2025
Q4 		$13 Hold
8
– – ﹤0.01% 3836
2025
Q3 		$9 Hold
8
– – ﹤0.01% 3727
2025
Q2 		$9 Hold
8
– – ﹤0.01% 3587
2025
Q1 		$7 Hold
8
– – ﹤0.01% 3537
2024
Q4 		$7 Hold
8
– – ﹤0.01% 3475
2024
Q3 		$13 Hold
8
– – ﹤0.01% 3372
2024
Q2 		$13 Hold
8
– – ﹤0.01% 3268
2024
Q1 		$18 Hold
8
– – ﹤0.01% 3197
2023
Q4 		$18 Hold
8
– – ﹤0.01% 3110
2023
Q3 		$24 Hold
8
– – ﹤0.01% 2965
2023
Q2 		$33 Hold
8
– – ﹤0.01% 2992
2023
Q1 		$30 Hold
8
– – ﹤0.01% 2967
2022
Q4 		$45 Hold
8
– – ﹤0.01% 2961
2022
Q3 		$0 Hold
8
– – ﹤0.01% 2830
2022
Q2 		$0 Buy
+8
New +$76 ﹤0.01% 2830
2021
Q4 		$0 Sell
14
-15
-52% -$450 ﹤0.01% 3626
2021
Q3 		$1K Hold
29
– – ﹤0.01% 3606
2021
Q2 		$2K Hold
29
– – ﹤0.01% 3432
2021
Q1 		$2K Buy
+29
New +$2.27K ﹤0.01% 3275

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harbour Investments's TXMD Position: Q1 2026 in Review

Harbour Investments held its TherapeuticsMD (TXMD) position steady in Q1 2026 at 8 shares worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #4631.

Harbour Investments first reported a position in TXMD in Q1 2021 and has held it in 20 quarters since. The position peaked at $2K in Q2 2021. 49 funds tracked by Wall St. Rank hold TXMD as of Q1 2026.

  • Harbour Investments held 8 shares of TherapeuticsMD worth $16 as of Q1 2026.
  • Harbour Investments left its TherapeuticsMD share count unchanged in Q1 2026.
  • TherapeuticsMD made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #4631 holding.
  • Harbour Investments first reported a position in TherapeuticsMD in Q1 2021 and has held it in 20 quarters since.
  • Harbour Investments's TherapeuticsMD position peaked at $2K in Q2 2021.
  • 49 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.